Name: Hemp-Derived CBD Extraction & Formulation
Brand: Islet Holdings Inc

Manufacturing and Industry

Islet Holdings Inc. offers a patented microencapsulation technology designed to protect transplanted islet cells from the recipient's immune system. This innovative approach enhances the survival and function of transplanted cells, leading to improved long-term outcomes for patients with insulin-dependent diabetes. The technology involves creating biocompatible microcapsules that shield the islet cells from immune attack, promoting successful integration and insulin production within the patient's body.

Islet Cell Microencapsulation Technology

Health and Medical

Pharmaceutical

Islet Holdings Inc

Utah

Manufacturing

Biopharma

Islet Holdings Inc. is developing intellectual property related to the extraction and formulation of cannabidiol (CBD) from hemp. This research aims to explore the potential therapeutic applications of CBD in various medical fields, leveraging our expertise in cell preservation and biocompatible materials.  We are focused on creating high-quality, standardized CBD products for potential future applications.

Hemp-Derived CBD Extraction & Formulation

Other products/services from Islet Holdings Inc

Islet Cell Microencapsulation Technology

N/A